AR and partial androgen insensitivity syndrome: To determine if E2 γ-carboxylation mediates the effect of warfarin on AR activity, we mutated the E2 residue into aspartate, which would preserve the charge but prevent γ-carboxylation, or lysine, the mutation observed in PAIS patients.